4//SEC Filing
LEDERMAN SETH 4
Accession 0001387131-22-003991
CIK 0001430306other
Filed
Mar 27, 8:00 PM ET
Accepted
Mar 28, 8:00 AM ET
Size
10.7 KB
Accession
0001387131-22-003991
Insider Transaction Report
Form 4
LEDERMAN SETH
DirectorPresident and CEO
Transactions
- Purchase
Common Stock, $0.001 par value
2022-03-25$0.24/sh+100,000$24,500→ 112,177 total
Holdings
- 459(indirect: By IRA)
Common Stock, $0.001 par value
- 30(indirect: By Starling Pharmaceuticals, Inc.)
Common Stock, $0.001 par value
- 135,000(indirect: By 401(k))
Common Stock, $0.001 par value
- 205(indirect: By LLC)
Common Stock, $0.001 par value
- 33(indirect: By LLC)
Common Stock, $0.001 par value
- 30(indirect: By Leder Laboratories, Inc.)
Common Stock, $0.001 par value
- 59(indirect: By LLC)
Common Stock, $0.001 par value
- 31(indirect: By Spouse)
Common Stock, $0.001 par value
Footnotes (1)
- [F1]Reporting person may be deemed to be a control person of this entity.
Issuer
Tonix Pharmaceuticals Holding Corp.
CIK 0001430306
Entity typeother
Related Parties
1- filerCIK 0001563420
Filing Metadata
- Form type
- 4
- Filed
- Mar 27, 8:00 PM ET
- Accepted
- Mar 28, 8:00 AM ET
- Size
- 10.7 KB